在慢性性肺病中个性化气道清除:一个范围审查
Lynne M Schofield1,2, Sally J Singh3, Zarah Yousaf4
1Faculty of Medicine Dentistry and Health, IICD, University of Sheffield, Sheffield, UK.
ERJ open research
|June 21, 2023
概括
针对慢性肺部疾病的个性化气道清除技术 (ACT) 得到了广泛讨论,并确定了七个关键因素来定制治疗方案. 本综述提出了一个模型来指导物理治疗师在个性化ACT更好的粘液清除.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 物理治疗 物理治疗
- 肺部康复治疗 肺部康复治疗
背景情况:
- 个性化气道清除技术 (ACT) 对于在慢性支性肺部疾病中管理粘液清除至关重要.
- 目前的文献缺乏关于个性化ACT治疗方案的具体指导方针的明确性.
- 本范围审查通过探索关于ACT个性化的研究来解决这个差距.
研究的目的:
- 探索当前关于慢性支性肺部疾病中呼吸道清除技术的研究.
- 确定ACT个性化可用的指导的范围和类型.
- 识别知识缺口和物理治疗师在ACT个性化中需要考虑的因素.
主要方法:
- 在多个数据库 (MEDLINE,EMBASE,CINAHL,PEDro,Cochrane,Web of Science) 进行系统的文献搜索,寻找过去25年的出版物.
- 利用并修改了TIDieR数据图表框架,开发了一个"最适合"的框架.
- 将发现转化为个性化模型.
主要成果:
- 审查了各种各样的出版物,最常见的是一般性审查论文 (44%).
- 确定了七个关键的个性化因素:身体,心理社会,ACT类型,程序,剂量,反应和提供者.
- 基于已识别的因素,针对物理治疗师开发了一个个性化模型,因为现有的模型有限.
结论:
- 气道清理方案的个性化在当前文献中得到了广泛的讨论.
- 已经确定了影响ACT个性化的一系列因素.
- 本综述将这些发现综合到一个拟议的气道清除个性化模型中,以提高清晰度和指导实践.
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Nursing Management
4.0K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
4.0K
Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
COPD: Management Using Bronchodilators and Corticosteroids
255
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
255


